[Results of the controlled experiment of new anti-inflammatory agent, Clonixin, in chronic rheumatoid arthritis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D014052:Toluidines / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D010919:Placebos; D014052:Toluidines